Drug and medical device makers didn’t oppose Robert F. Kennedy Jr.’s confirmation as health secretary, but are speaking up in ...

The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong ...

Jefferies pointed out that India currently imposes up to 10% import duties on US drugs, with some having lower duties or ...

Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...

The day of reckoning for tariffs is rapidly approaching, and we're anticipating substantial disruption for the pharmaceutical ...

The pharmaceutical company lowers costs of medications for everyday consumers—but Trump’s tariffs might make that more ...

No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

What Liberation Day means for you, a stock with high steam, ITC’s play on valuation, the rate cut suspense, and much more ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data ...

Learn more about whether Jazz Pharmaceuticals plc or Viatris Inc. is a better investment based on AAII's A+ Investor grades, ...